Literature DB >> 33031863

Impact of COVID-19 prevention measures on risk of health care-associated Clostridium difficile infection.

Enrico Bentivegna1, Giuliano Alessio2, Valerio Spuntarelli3, Michelangelo Luciani4, Iolanda Santino5, Maurizio Simmaco6, Paolo Martelletti7.   

Abstract

Clostridium difficile is the most common pathogen between health care-associated infections and its incidence has increased during the last years. lack of enough evidence about effective hygiene interventions to prevent this disease. Due to the coronavirus disease 2019 (COVID‑19) pandemic, several strategies to reduce microorganism spread were adopted in hospital setting. The objective of this study was to establish whether such strategies can reduce health care associated C difficile infection (HA-CDI) incidence. We found that, during the pandemic (2020) HA-CDI incidence was significantly lower with respect to the previous years. This work demonstrates that maintaining this level of attention regarding control activities related to prevention of microorganism transmission significantly reduce HA-CDI and related expenses in terms of health costs and human lives.
Copyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Infections control; Nosocomial infections; Personal-protective equipements; SARS-CoV-2

Year:  2020        PMID: 33031863      PMCID: PMC7534787          DOI: 10.1016/j.ajic.2020.09.010

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


Background

Clostridium difficile (CD) is the most common pathogen among health care-associated (HA) infections. , An important obstacle in prevention of C difficile infection (CDI) is the lack of enough evidence about effective hygiene interventions to prevent this disease. Although preventive contact precautions are recommended, there are no sufficient data on their effectiveness for its prevention. , Due to the coronavirus disease 2019 (COVID-19) pandemic, several strategies to reduce microorganism spread were adopted in hospital setting. The objective of this study was to establish whether such strategies can reduce HA-CDI incidence. The primary task was to identify differences on HA-CDI incidence in medical wards before and during the COVID-19 pandemic. The secondary task was to evaluate if severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection could influence the incidence of CDI.

Methods

We conducted a retrospective analysis on medical wards’ discharges (n. 1617) in S. Andrea Hospital (Rome) from March 1 to June 30, 2020 comparing data before (2017, 2018, and 2019) and during (2020) the COVID-19 pandemic. Intensive care units and paediatric wards were excluded. CDI diagnosis was confirmed by clinical suspicious (presence of diarrhea defined as ≥3 unformed stools in 24 hours) plus stool tests positive for CD. HA-CDI incidence was depicted as CDI diagnosed ≥72 hours after admission per 100 total discharges. Data was collected using Excel Office, and χ² test was performed to detect differences in HA-CDI incidence between different groups. Value of P< .05 was considered as significant.

Results

The number of discharges and HA-CDI diagnosis for each medical ward is reported in Table 1 . No statistically significant difference of HA-CDI incidence between years 2017, 2018, and 2019 was observed. Conversely, during the pandemic (2020) HA-CDI incidence was significantly lower with respect to 2017 (odds ratio [OR] = 2.98; P = .002), 2018 (OR = 2.27; P = .023) and 2019 (OR = 2.07; P = .047) (see Table 1 and Fig. 1 ). Interestingly, during 2020, COVID-19 departments showed higher HA-CDI incidence respect to Covid-19 free wards (not significative). This data suggests SARS-Cov2 infection as a possible risk factor for CDI in agreement with recent evidences that report altered gut microbiota in COVID-19 patients. Furthers studies are needed to confirm this hypothesis.
Table 1.

Data from medical departments between March, 1 and June, 30

DischargesNumber of HD-CDIHA-CDI incidence
2017422390.092
2018348250.072
2019364240.066
2020 (Covid-19 free)333110.033*
2020 (Covid-19)15070.047

During 2020 Covid-19-free departments shown lower incidence of HA-CDI compared to the previously years (*P < .05). Covid-19 departments shown higher HA-CDI incidence than Covid-19-free departments of the same year (not significative).

Fig 1.

Data from medical departments between March, 1 and June, 30, 2020. During 2020 Covid-19-free departments shown lower incidence of HA-CDI compared to the previously years (* = P < .05). Covid-19 departments shown higher HA-CDI incidence than Covid-19-free departments of the same year (not significative).

Data from medical departments between March, 1 and June, 30 During 2020 Covid-19-free departments shown lower incidence of HA-CDI compared to the previously years (*P < .05). Covid-19 departments shown higher HA-CDI incidence than Covid-19-free departments of the same year (not significative). Data from medical departments between March, 1 and June, 30, 2020. During 2020 Covid-19-free departments shown lower incidence of HA-CDI compared to the previously years (* = P < .05). Covid-19 departments shown higher HA-CDI incidence than Covid-19-free departments of the same year (not significative).

Discussion

CDI incidence has increased from 4.5/1000 adult discharge in 2001 to 8.2/1000 discharge in 2010 with annual health care costs that exceed $1.5 billion in the United States. Several studies have been carried out to identify CDI prevention strategies in hospital setting. Although contact precautions, personal protective equipment (PPE) employments and healthcare workers hygiene education are strongly recommended, as of today, evidence for their effectiveness in CDI prevention is still weak. , Although within a limited period of observation, this work provides evidences for such strategies’ effectiveness in reducing HA-CDI incidence. From the beginning of the pandemic, PPE (surgical masks, latex gloves, and disposable medical coats) were employed by health care workers and a greater attention has been paid to frequent handwashing and surfaces disinfection. Relatives’ visits to patients were limited to only one family member at a time and were reduced from 2 to 1 time per day. Each visitor had to wear PPE described above and adopt the social distancing measures recommended by the World Health Organization (WHO). We report a significant reduction of HA-CDI incidence while using these precautions. Our study does not tell which one of the prevention measures adopted during emergency played a major role in this modification. Previous studies demonstrated that intensified hand-hygiene practices alone were not effective in preventing CDI. We can therefore speculate that all practices described above adopted in their complex along with greater attention paid by health personnel have led to lower CD spread. HA infections frequency is an indicator of the health care quality. Previous studies demonstrated how health workers' hygiene errors are at the base of microorganism spread in hospital setting: in particular, protocol deviations during PPE donning and doffing are common and cause self-contamination. The COVID-19 emergency has led to extraordinary levels of attention by all health care personnel regarding control activities related to prevention of microorganism transmission. This study demonstrates that maintaining this level of preventive measure over time would significantly reduce HA-CDI and related expenses in terms of health costs and human lives.
  26 in total

1.  COVID-19 Prevention Practices and Determinant Factors Among Healthcare Professionals Working in Hospitals of South Gondar Zone, Northwestern Ethiopia.

Authors:  Zebader Walle; Gete Berihun; Awoke Keleb; Daniel Teshome; Leykun Berhanu
Journal:  J Multidiscip Healthc       Date:  2021-08-22

2.  COVID-19 and Fulminant Clostridium difficile Colitis Co-Infection.

Authors:  Abdul Ahad Ehsan Sheikh; Abu Baker Sheikh; Ishan Shah; Ali Hamza Khair; Nismat Javed; Rahul Shekhar
Journal:  Eur J Case Rep Intern Med       Date:  2021-08-24

Review 3.  Empiric Antibiotics in COVID 19: A Narrative Review.

Authors:  Elvina C Lingas
Journal:  Cureus       Date:  2022-06-02

4.  Proper use of noncontact infrared thermometry for temperature screening during COVID-19.

Authors:  Amber S Hussain; Heather S Hussain; Nathan Betcher; Robert Behm; Burt Cagir
Journal:  Sci Rep       Date:  2021-06-04       Impact factor: 4.379

5.  How the COVID-19 pandemic changed postoperative infections in urology wards: A retrospective cohort study from two urology departments.

Authors:  Bernardo L Teixeira; João Cabral; André Marques-Pinto; Fernando Vila; Joaquim Lindoro; Avelino Fraga
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

6.  Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?

Authors:  Dominique L Monnet; Stephan Harbarth
Journal:  Euro Surveill       Date:  2020-11

Review 7.  Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use.

Authors:  Ravina Kullar; Stuart Johnson; Lynne V McFarland; Ellie J C Goldstein
Journal:  Antibiotics (Basel)       Date:  2021-04-09

Review 8.  How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?

Authors:  Masoumeh Azimirad; Maryam Noori; Hamideh Raeisi; Abbas Yadegar; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Enrico Bentivegna; Paolo Martelletti; Nicola Petrosillo; Mohammad Reza Zali
Journal:  Front Med (Lausanne)       Date:  2021-12-13

9.  Unintended consequences of infection prevention and control measures during COVID-19 pandemic.

Authors:  Liang En Ian Wee; Edwin Philip Conceicao; Jing Yuan Tan; Kamini Devi Magesparan; Ismawati Binte Mohamad Amin; Bushra Binte Shaik Ismail; Hui Xian Toh; Pinhong Jin; Jing Zhang; Elaine Geok Ling Wee; Sheena Jin Min Ong; Gillian Li Xin Lee; Amanda En-Min Wang; Molly Kue Bien How; Kwee Yuen Tan; Lai Chee Lee; Poh Choo Phoon; Yong Yang; May Kyawt Aung; Xiang Ying Jean Sim; Indumathi Venkatachalam; Moi Lin Ling
Journal:  Am J Infect Control       Date:  2020-11-04       Impact factor: 2.918

Review 10.  Clostridioides difficile infection (CDI) during the COVID-19 pandemic.

Authors:  Patrizia Spigaglia
Journal:  Anaerobe       Date:  2022-01-19       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.